Foundry Partners, LLC Sanofi Transaction History

Foundry Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$45.75 - $52.48 $5.15 Million - $5.9 Million	-112,504 Reduced 41.35%	159,556 $7.75 Million
Q4 2023 Feb 01, 2024	SELL	$43.13 - $54.79 $1.45 Million - $1.85 Million	-33,690 Reduced 11.02%	272,060 $13.5 Million
Q3 2023 Nov 09, 2023	SELL	$50.95 - $55.2 $95,225 - $103,168	-1,869 Reduced 0.61%	305,750 $16.4 Million
Q2 2023 Jul 12, 2023	SELL	$50.45 - $57.18 $4.42 Million - $5.01 Million	-87,556 Reduced 22.16%	307,619 $16.6 Million
Q1 2023 May 03, 2023	BUY	$45.86 - $54.45 $18.1 Million - $21.5 Million	395,175 New	395,175 $21.5 Million

810

267M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $136B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.